Calciphylaxis clinical trials
The registry lists 23 studies for Calciphylaxis across more than 10 countries. 10 are recruiting or about to start. 19 of them are mainly about Calciphylaxis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Calciphylaxis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Massachusetts General Hospital (2) · Sanifit Therapeutics S. A. (2) · Hope Pharmaceuticals (2) · Association ECHO (1) · Sagar U. Nigwekar, MD, MMSc (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Centre Hospitalier St Esprit (1) · U.S. Wound Registry (1)
What is being tested here
Drugs under test in Calciphylaxis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Apr 2027Rheopheresis as Adjuvant Treatment of Calciphylaxis · University Hospital, Lille
- Sep 2027Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis · The First Affiliated Hospital with Nanjing Medical University
Who these studies take
Of the 7 Calciphylaxis studies recruiting now, 6 (86%) set no upper age limit and 1 (14%) stop at 75 or younger. 2 (29%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (14%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (29%) | 2 (29%) |
| 18 | 7 (100%) | 7 (100%) |
| 30 | 7 (100%) | 7 (100%) |
| 40 | 7 (100%) | 7 (100%) |
| 50 | 7 (100%) | 7 (100%) |
| 65 | 7 (100%) | 7 (100%) |
| 75 | 7 (100%) | 7 (100%) |
| 85 | 6 (86%) | 6 (86%) |
Across all 23 studies, recruiting or not: 9% stop at 75 or younger and 0% at 65; 13% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Study of EPN-701 for the Treatment of CalciphylaxisNot yet recruitingNCT07583745Phase 21 country
- Partners Calciphylaxis BiobankRecruitingNCT030328351 country
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- Anti-Interleukin-6 (IL6) in CalciphylaxisNot yet recruitingNCT07708038Phase 11 country
- Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)RecruitingNCT075112831 country
- Human Amniotic-Derived Mesenchymal Stem Cell Therapy for CalciphylaxisRecruitingNCT04592640Early Phase 11 country
- Rheopheresis as Adjuvant Treatment of CalciphylaxisRecruitingNCT04654000Not applicable1 country
- Better Evidence and Translation for CalciphylaxisRecruitingNCT05018221Phase 32 countries
- A Real-World Registry of Chronic Wounds and UlcersRecruitingNCT022807331 country
- National Registry of Rare Kidney DiseasesRecruitingNCT060658521 country
- SEAPORT 1: Study of INZ-701 in Adults With Hemodialysis-Dependent End-Stage Kidney DiseaseCompletedNCT06283589Phase 11 country
- Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and OutcomeCompletedNCT028540461 country
- Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic ArteriolopathyWithdrawnNCT02527213Phase 31 country
- Phase 3 Study of SNF472 for CalciphylaxisCompletedNCT04195906Phase 36 countries
- Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)CompletedNCT056331211 country
- Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)CompletedNCT015783821 country
- A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis PatientsTerminatedNCT03150420Phase 33 countries
- Evaluation of Vitamin K Supplementation for Calcific Uremic ArteriolopathyCompletedNCT02278692Not applicable1 country
- Phase 2 Study With SNF472 in Calciphylaxis PatientsCompletedNCT02790073Phase 22 countries
- Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium ThiosulfateTerminatedNCT033199141 country
- The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National CohortStatus unknownNCT031467931 country
- European Calciphylaxis Registry NetworkStatus unknownNCT026353731 country
- Efficacy of Lanthanum Carbonate in CalciphylaxisCompletedNCT01289626Phase 11 country